This is not just something to push through.
A Stanford Medicine study of 2.5 million California births has placed a long-dismissed condition — severe pregnancy nausea known as hyperemesis gravidarum — into the clearer light of medical consequence. What many women were told to endure in silence turns out to carry measurable, significant risks: higher rates of preeclampsia, preterm birth, anemia, and placental complications. The study arrives as treatment options improve, offering a rare convergence of new knowledge and new tools — but only if the medical community chooses to act on both.
- Hyperemesis gravidarum, affecting 1–3% of pregnancies, causes relentless vomiting, dangerous weight loss, and nutrient deprivation severe enough to require emergency hospitalization.
- Women hospitalized for HG face up to 37% higher risk of serious complications — including preeclampsia, early delivery, and placental abruption — compared to unaffected pregnancies.
- The underlying danger appears to be malnutrition: when the body cannot absorb essential nutrients, placental development falters, cascading into complications for both mother and infant.
- The longer HG goes untreated, the worse the outcomes — women first hospitalized in the second trimester faced higher complication rates than those treated earlier, underscoring the cost of delay.
- Newer FDA-approved medications and updated clinical guidelines now exist, but researchers warn they must be applied earlier and more aggressively to meaningfully change outcomes.
- Women with HG are urged to advocate for themselves — requesting monitoring and treatment rather than waiting — because this condition is not something to simply push through.
A Stanford Medicine study examining 2.5 million California births has confirmed what many women with severe pregnancy nausea have long suspected: the condition is not merely miserable — it is medically dangerous. Published in the American Journal of Epidemiology, the research is the first large, population-based U.S. study of hyperemesis gravidarum, or HG, a condition affecting 1 to 3 percent of pregnancies that goes far beyond ordinary morning sickness.
While most pregnant women experience some nausea that resolves on its own, HG is relentless. Women with the condition endure severe, sustained vomiting throughout pregnancy, struggle to absorb essential nutrients like folate, and can lose more than 15 percent of their pre-pregnancy weight at a time when their bodies should be building new life. Many require emergency hospitalization.
The Stanford team focused on roughly 53,700 births — about 2.2 percent of their dataset — where mothers had been hospitalized for HG. Compared to unaffected pregnancies, these women faced an 18 percent higher risk of preeclampsia, a 25 percent greater chance of preterm delivery, a 37 percent higher risk of anemia, and a 14 percent increased likelihood of placental abruption. Their infants were also significantly more likely to be born smaller than expected.
The mechanism appears rooted in malnutrition. When a pregnant woman cannot keep food down, her body struggles to build and sustain the placenta — the organ on which fetal development depends. Lead researcher Rebecca Gardner noted that the timing of hospitalization mattered: women first treated in the second trimester fared worse than those treated in the first, suggesting that prolonged nutritional deprivation compounds the harm.
The findings arrive as the medical landscape is shifting. Updated guidelines from the American College of Obstetricians and Gynecologists now encourage faster, more aggressive treatment of pregnancy nausea, and two medications are FDA-approved specifically for the condition. Gardner suggested that preventive measures like low-dose aspirin — already used in other high-risk pregnancies — may also deserve consideration for HG patients.
For clinicians, the study is a call to monitor HG pregnancies more closely. For patients, Gardner's message was direct: most HG pregnancies do end well, but the condition must be taken seriously. Women should ask their doctors about additional monitoring and treatment — and stop waiting to be told it is safe to struggle in silence.
A Stanford Medicine study of 2.5 million California births has documented what many pregnant women with severe nausea have long suspected: the condition is not merely uncomfortable—it carries real medical danger. The research, published in June in the American Journal of Epidemiology, is the first large, population-based examination in the United States of hyperemesis gravidarum, or HG, a condition that affects between 1 and 3 percent of pregnancies and goes far beyond typical morning sickness.
While 70 to 80 percent of pregnant women experience some nausea during pregnancy, it typically resolves without lasting harm. HG is different. Women with the condition endure severe, relentless nausea and vomiting that can persist throughout their entire pregnancy. They struggle to eat, to stay hydrated, to absorb the nutrients—particularly folate—that are essential in early pregnancy. Some lose more than 15 percent of their pre-pregnancy weight at a time when they should be gaining. The condition is severe enough to require hospitalization for emergency care.
The Stanford team examined birth records from 2007 to 2011, focusing on pregnancies where the mother had been hospitalized for HG. Of the 2.47 million births in their final analysis, about 53,700—or 2.2 percent—involved mothers who received emergency or inpatient care for the condition. When researchers compared these pregnancies to those without HG hospitalizations, the differences were striking. Women hospitalized for HG faced an 18 percent higher risk of preeclampsia, a dangerous pregnancy complication that can trigger seizures if left untreated. They were 25 percent more likely to deliver prematurely—three or more weeks before their due date. Their risk of anemia jumped by 37 percent. They were 14 percent more likely to experience placental abruption, in which the placenta detaches from the uterus before delivery. And their babies were significantly more likely to be born smaller than expected for their stage of development.
The mechanism appears to be rooted in malnutrition. When a pregnant woman cannot keep food down and loses significant weight, her body struggles to build and maintain the placenta properly. Rebecca Gardner, the lead researcher and a Stanford epidemiology graduate student, explained that inadequate nutrient absorption likely impairs placental development, which in turn increases the risk of complications like preeclampsia and growth restriction. The timing of hospitalization mattered too: women who were first hospitalized during the second trimester faced higher complication rates than those hospitalized in the first trimester, suggesting that prolonged nutritional deprivation compounds the risk.
Previous research on HG and pregnancy outcomes had significant limitations. Most studies were small, and nearly all drew from European populations with different demographic profiles and healthcare systems than the United States. This Stanford study, by contrast, examined a large and diverse population with access to detailed medical records, demographic information, and social vulnerability data. It provides the clearest picture yet of what HG actually costs.
The findings arrive at a moment when treatment options are evolving. In 2018, after the data for this study had been collected, the American College of Obstetricians and Gynecologists updated its guidelines to encourage faster and more aggressive treatment of pregnancy nausea. Two medications are now FDA-approved specifically for nausea and vomiting in pregnancy. Gardner noted that further research could clarify whether these newer approaches reduce the complications her team documented. She also suggested that HG might warrant additional preventive measures, such as low-dose aspirin, which is already used to prevent preeclampsia in other high-risk pregnancies.
For physicians, the message is clear: pregnancies marked by HG hospitalization should trigger closer monitoring for the specific complications the study identified. For pregnant women, Gardner offered a direct message: most HG pregnancies do result in healthy outcomes for both mother and baby, but the condition demands to be taken seriously. It is not something to endure silently. Women should advocate for themselves, asking their doctors whether they need additional monitoring or anti-nausea medication. As Gardner put it, this is not simply something to push through.
Notable Quotes
Hyperemesis gravidarum is not just bad morning sickness; it's severe enough to cause dehydration and significant weight loss.— Rebecca Gardner, lead study author
Pregnant women need to know that most HG pregnancies still result in healthy outcomes for the mom and baby, but HG does need to be taken seriously.— Rebecca Gardner
The Hearth Conversation Another angle on the story
Why does this study matter now? Haven't doctors known that severe nausea in pregnancy is bad?
They suspected it, but they didn't have solid proof from a large American population. Most previous research was small and came from Europe, where healthcare systems and populations are structured differently. This study of 2.5 million births gives us the first clear picture of how much danger HG actually poses.
What exactly is the danger? Is it just that the baby is smaller?
It's broader than that. Yes, babies are smaller, but mothers also face preeclampsia—a serious condition that can cause seizures—early delivery, severe anemia, and placental abruption. The underlying problem is that women with HG can't absorb nutrients. They lose weight when they should be gaining it. That malnutrition seems to damage how the placenta develops, which cascades into multiple complications.
How much more likely are these complications?
It varies. Women with HG are about 25 percent more likely to deliver early, 37 percent more likely to be anemic, 18 percent more likely to have preeclampsia. Those percentages might not sound enormous, but when you're talking about a serious condition like preeclampsia that can be life-threatening, even an 18 percent increase matters.
The study looked at women hospitalized for HG. Does that mean milder cases are safer?
Probably, yes. The study specifically examined pregnancies severe enough to require emergency or hospital care. But the fact that hospitalization was needed tells you something—these weren't women who could manage at home. And even among those, timing mattered. Women first hospitalized in the second trimester had worse outcomes than those hospitalized in the first trimester, suggesting that prolonged malnutrition compounds the risk.
What changes now?
The guidelines for treating HG already changed in 2018, after this data was collected. Doctors are now encouraged to treat nausea faster and more aggressively, and there are FDA-approved medications. But we don't yet know if those newer approaches actually prevent the complications this study found. That's the next question. Also, doctors should probably monitor HG pregnancies more closely and consider preventive measures like low-dose aspirin.
What should a pregnant woman with HG do with this information?
Take it seriously. Don't assume it's just bad morning sickness that you have to endure. Ask your doctor about anti-nausea medication, about closer monitoring, about whether you need additional preventive care. Most HG pregnancies still result in healthy outcomes, but the condition demands attention and advocacy.